Hap Trading, LLC Anavex Life Sciences Corp. Put Options Transaction History

Hap Trading, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 12, 2022	SELL	$7.31 - $12.84 $45,322 - $79,608	-6,200 Reduced 34.25%	11,900 $68,000
Q1 2022 May 12, 2022	SELL	$9.74 - $17.69 $74,998 - $136,213	-7,700 Reduced 29.84%	18,100 $72,000
Q4 2021 Feb 14, 2022	BUY	$16.88 - $23.31 $138,416 - $191,142	8,200 Added 46.59%	25,800 $123,000
Q3 2021 Nov 10, 2021	BUY	$16.82 - $25.75 $104,284 - $159,650	6,200 Added 54.39%	17,600 $92,000
Q2 2021 Aug 11, 2021	BUY	$10.16 - $28.86 $115,824 - $329,004	11,400 New	11,400 $9,000
Q2 2020 Aug 10, 2020	SELL	$2.62 - $5.2 $28,820 - $57,200	-11,000 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$2.38 - $5.81 $26,180 - $63,909	11,000 New	11,000 $22,000

155

27.3M

515K

838K

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $847M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.